2.1
Loncastuximab tesirine (Zynlonta, Swedish Orphan Biovitrum) is indicated for 'the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL), after two or more lines of systemic therapy.'